A Study of Brenipatide in Adults Who Quit Smoking Cigarettes and Want to Avoid Relapse (NCT07223840)
A Phase 2, Multicenter, Randomized, Double-Blind Study to Investigate the Efficacy and Safety of Brenipatide Compared With Placebo for Reduction in Risk of Relapse to Cigarette Smoking in Adults (RENEW-Smk-1)
🩺 Plain-English Summary (8th-Grade Level)
This study evaluates the efficacy and safety of brenipatide when compared to placebo for reducing the risk of relapse to cigarette smoking in adults who have recently quit. Study participation will last approximately 34 weeks with up to 17 study visits, which includes a 2-week screening period, 24-week treatment period, 8-week safety follow-up period.
Who can join: Review the eligibility criteria below.
Location: Woodland Research Northwest — Rogers, Arkansas
Age range: 18 Years to 75 Years
🧪 Interventions in This Study
📋 "Do I Qualify?" — 1-Minute Self Screener
Instant ChecklistFull eligibility criteria are available on the official NIH protocol. View the criteria ↗
📍 All Participating Trial Locations (29 Sites)
Showing the first 25 of 29 sites.
- Woodland Research Northwest — Rogers, Arkansas
- Hillcrest Medical Research — DeLand, Florida
- TecTum Research — Hollywood, Florida
- K2 Medical Research ORLANDO — Maitland, Florida
- GTL Medical & Research Group — Miami, Florida
- Conquest Research - Orlando — Orlando, Florida
- North Georgia Clinical Research — Woodstock, Georgia
- Revival Research Institute, LLC — Dearborn, Michigan
- Arch Clinical Trials — St Louis, Missouri
- Vector Clinical Trials — Las Vegas, Nevada
- Rochester Clinical Research, LLC — Rochester, New York
- Coastal Carolina Research Center — North Charleston, South Carolina
- Circle Clinical Research — Sioux Falls, South Dakota
- FutureSearch Trials of Dallas — Dallas, Texas
- Adams Clinical Dallas — DeSoto, Texas
- The University of Texas Health Science Center at Houston — Houston, Texas
- Health Research of Hampton Roads, Inc. — Newport News, Virginia
- Eastside Research Associates — Redmond, Washington
- Beijing Chaoyang Hospital, Capital Medical University — Beijing,
- Beijing Anding Hospital - Affiliated Capital University of Medical Science — Beijing,
- Sichuan Provincial People's Hospital — Chengdu,
- 2nd Affiliated Hospital Chongqing Medical University — Chongqing,
- Sir Run Run Shaw Hospital of Zhejiang University School of Medicine — Hangzhou,
- Taizhou Hospital of Zhejiang Province — Linhai,
- The first affiliated hospital of Ningbo university — Ningbo,
📞 Contact the Study Coordinator
Phone: (317) 615-4559
Email: LillyTrials@Lilly.com
Coordinator details come directly from the registered NIH protocol. Confirm the study is still recruiting before traveling.
💰 Cost, Insurance & Patient Rights
- 100% Free Items: The investigational treatment and protocol-required procedures are supplied at zero cost by the sponsor.
- Routine Patient Care: Under federal law (ACA § 2709) and many state statutes, routine care costs are covered during participation.
- Voluntary Participation: You may withdraw at any time without affecting your standard medical care.
More studies in Smoking
- Centralized Lung Cancer EARly Detection Among Smokers (CLEAR Study) — Galveston, Texas
- Smartphone-delivered Scheduled Smoking With Compliance Facilitation as an Adjunct Cessation Therapy: a Feasibility Study — Houston, Texas
- The Effect of Tobacco Products on Wound Healing — Minneapolis, Minnesota
- Digitally Enhanced Smoking Cessation for High Risk Smokers — Boston, Massachusetts
- Reducing Tobacco-associated Lung Cancer Risk: A Randomized Clinical Trial of AB-free Kava — Gainesville, Florida
- A Study to Develop a Strategy to Increase Lung Cancer Screening in Women Who May Be at Risk for Lung Cancer — Basking Ridge, New Jersey
Explore by condition: All Smoking clinical trials
💡 How to Participate
- Check the checklist above to see if you may qualify.
- Contact the study coordinator using the phone/email above.
- Ask about the visit schedule, what is covered at no cost, and any travel support.
- Confirm with your own doctor before making a decision.